Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: Boosting nuclear-targeted photothermal-chemotherapy by NIR-responsive hybrid membrane camouflaged nanotherapeutics

Fig. 3

a Bright-field and SERS images of VE cells, HeLa cells and HepG2 cells incubated with PB@M NPs for 6 h based on the peak of 2152 cm−1. Scale bar: 10 μm. b Fluorescent images of HepG2 cells incubated with PB@D@M and FITC-PB@DN@M NPs without/with NIR irradiation. Scale bar: 50 μm. c AFM images and its adhesion mapping of HepG2 cells incubated with PB@HM, PB@RM and PB@M NPs for 6 h. Scale bar: 10 μm

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us